CHRRX
Price
$22.25
Change
-$0.21 (-0.93%)
Updated
Jul 13 closing price
Net Assets
3.75B
VFFSX
Price
$367.80
Change
-$2.94 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

CHRRX vs VFFSX

CHRRX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
CHRRX vs. VFFSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHRRX is a StrongBuy and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. CHRRX (3.75B). VFFSX pays higher dividends than CHRRX: VFFSX (1.08) vs CHRRX (0.00). CHRRX was incepted earlier than VFFSX: CHRRX (24 years) vs VFFSX (10 years). CHRRX (1.26) is less costly to investors than VFFSX (0.01). CHRRX is a more actively managed with annual turnover of: 36.00 vs. VFFSX (2.00). CHRRX has a lower initial minimum investment than VFFSX: CHRRX (1000) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 21.07 vs. CHRRX (6.95). VFFSX return over 5 years is better than : 73.48 vs. CHRRX (10.38).
CHRRXVFFSXCHRRX / VFFSX
Total Expense Ratio1.260.0112,600%
Annual Report Gross Expense Ratio1.260.0112,600%
Fund Existence24 years10 years-
Gain YTD6.69810.68563%
Front LoadN/AN/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.75B1.67T0%
Annual Yield % from dividends0.001.08-
Returns for 1 year6.9521.0733%
Returns for 3 years31.0868.4545%
Returns for 5 years10.3873.4814%
Returns for 10 years26.20251.2110%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZIEX20.58N/A
N/A
Lazard International Equity Instl
CMNWX91.13N/A
N/A
Principal Capital Appreciation A
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6